We are live on ! Find out more
IIM

Illumine Investment Management Portfolio holdings

AUM $154M
1-Year Est. Return 52.22%
This Fund
S&P 500
This Quarter Est. Return
-1.31%
1 Year Est. Return
+52.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$122M
AUM Growth
+$592K
Cap. Flow
+$5.4M
Cap. Flow %
4.42%
Top 10 Hldgs %
31.72%
Holding
93
New
2
Increased
54
Reduced
16
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 23.09%
2 Healthcare 15.98%
3 Financials 12.31%
4 Industrials 8.73%
5 Consumer Discretionary 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DIVO icon
76
Amplify CWP Enhanced Dividend Income ETF
DIVO
$7.81B
$481K 0.39%
11,802
-2,460
-17% -$102K
NVDA icon
77
NVIDIA
NVDA
$5.43T
$471K 0.39%
4,342
+12
+0.3% +$1.52K
LLY icon
78
Eli Lilly
LLY
$1.09T
$454K 0.37%
550
ETH
79
Grayscale Ethereum Staking Mini ETF Shares
ETH
$1.72B
$430K 0.35%
24,947
+1,594
+7% +$39.5K
ORCL icon
80
Oracle
ORCL
$442B
$406K 0.33%
2,902
VVR icon
81
Invesco Senior Income Trust
VVR
$457M
$354K 0.29%
94,270
+11,963
+15% +$48.2K
ABBV icon
82
AbbVie
ABBV
$440B
$345K 0.28%
1,644
-71
-4% -$13.8K
AMP icon
83
Ameriprise Financial
AMP
$49.9B
$301K 0.25%
622
LOW icon
84
Lowe's Companies
LOW
$121B
$297K 0.24%
1,272
MRK icon
85
Merck
MRK
$328B
$264K 0.22%
2,940
AMZN icon
86
Amazon
AMZN
$2.88T
$209K 0.17%
1,100
BOE icon
87
BlackRock Enhanced Global Dividend Trust
BOE
$695M
$141K 0.12%
12,974
BKD icon
88
Brookdale Senior Living
BKD
$3.1B
$125K 0.1%
20,000
RC
89
Ready Capital
RC
$289M
$108K 0.09%
21,137
+756
+4% +$4.66K
FOCL
90
EDAP TMS S.A.
FOCL
$178M
$43.9K 0.04%
22,400
NCZ
91
Virtus Convertible & Income Fund II
NCZ
$306M
-4,695
Closed -$58.8K
NVO
92
Novo Nordisk
NVO
$203B
-2,812
Closed -$242K
SPY icon
93
State Street SPDR S&P 500 ETF Trust
SPY
$809B
-405
Closed -$237K

Similar funds

Illumine Investment Management's Q1 2025 Portfolio in Review

As of Q1 2025, Illumine Investment Management held 93 positions worth $122M, up 0.49% from $122M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Illumine Investment Management deployed $5.4M of net new capital in Q1 2025, opening 2 new positions and adding to 54 existing holdings. Its largest new stake was Axcelis: 9,731 shares worth $483K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Corcept Therapeutics, an estimated $491K trimmed.

  • Illumine Investment Management's largest Q1 2025 buy was Axcelis: 9,731 shares worth $483K.
  • Illumine Investment Management added most to Guggenheim Strategic Opportunities Fund in Q1 2025, an estimated $629K increase.
  • Illumine Investment Management's biggest Q1 2025 reduction was Corcept Therapeutics, cutting an estimated $491K.
  • Illumine Investment Management fully exited Novo Nordisk in Q1 2025, selling an estimated $242K.
  • Illumine Investment Management's ten largest holdings make up 32% of its $122M portfolio in Q1 2025.
  • Illumine Investment Management opened 2 new positions and closed 3 in Q1 2025.
  • Illumine Investment Management's portfolio value rose 0.49% quarter-over-quarter to $122M.

Based on Illumine Investment Management's 13F filing for Q1 2025, filed 22 Apr 2025.